Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

about

Baseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetate.Radiation recall pneumonitis induced by ifosfamide for malignant soft tissue tumor arising from the chest wall: A case report.

P2860

Q51740033-C5141B37-375C-4447-AE42-75B94B0EB82C Q55024584-86B6EFA9-FC9B-4991-B3CA-1D11F92B2E29

P2860

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

Item

http://www.wikidata.org/entity/Q36573310

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@ast

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@en

type

Item

label

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@ast

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@en

prefLabel

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@ast

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@en

P1476

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

@en

P2093

Anna Roma

http://www.w3.org/2001/XMLSchema#string

Giovanni Scarzello

http://www.w3.org/2001/XMLSchema#string

Maria Samaritana Buzzaccarini

http://www.w3.org/2001/XMLSchema#string

Pasquale Fiduccia

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.

Cumulative illness rating scale.

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

P2888

s00432-015-2065-4

P304

679-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-015-2065-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P50

Mario Domenico Rizzato

P577

2015-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283576993

http://www.w3.org/2001/XMLSchema#string

P698

26547435

http://www.w3.org/2001/XMLSchema#string

P932

4751155

http://www.w3.org/2001/XMLSchema#string

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

about

P2860

P2860

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932